ORIGINAL RESEARCH article

Front. Pediatr.

Sec. Pediatric Pulmonology

Volume 13 - 2025 | doi: 10.3389/fped.2025.1482880

This article is part of the Research TopicPulmonary infection in childrenView all 5 articles

Co-detection of respiratory pathogens in children with Mycoplasma pneumoniae pneumonia: A multicenter study

Provisionally accepted
Xiaoyan  DongXiaoyan Dong1Rui  LiRui Li1ZOU  YINGXUEZOU YINGXUE2Lina  ChenLina Chen3Hailin  ZhangHailin Zhang4Fangfang  LvFangfang Lv4Wenhao  YangWenhao Yang3Niu  YanhuaNiu Yanhua1Haojie  WangHaojie Wang1Run  GuoRun Guo2Xu  WangXu Wang2Li  LiLi Li2Zihao  LinZihao Lin4Li  LuoLi Luo5Danli  LuDanli Lu3Quan  LuQuan Lu1*Hanmin  LiuHanmin Liu3*
  • 1Shanghai Children's Hospital, Shanghai, China
  • 2Tianjin Children's Hospital, Tianjin, China
  • 3West China Second University Hospital, Sichuan University, Chengdu, Sichuan Province, China
  • 4Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China
  • 5Ya'an People’s Hospital, Yaan, Sichuan Province, China

The final, formatted version of the article will be published soon.

Objective: To investigate the prevalence and clinical significance of respiratory pathogen co-detection in children diagnosed with Mycoplasma pneumoniae pneumonia (MPP). Methods: A prospective observational multicenter study was conducted, collecting clinical data from pediatric patients diagnosed with MPP in four hospitals across China from December 1 to December 31, 2023. Targeted next-generation sequencing (tNGS) results and clinical characteristics were analyzed. Participants were divided into mild and severe groups according to disease severity. Severe cases were further subdivided into an MP alone group and a multi-pathogen co-detection group. Receiver operating characteristic (ROC) curve analysis was performed to assess the predictive performance of inflammatory biomarkers for multi-pathogen co-detection.Results: A total of 266 children were enrolled. Severe cases had significantly higher C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), lactate dehydrogenase (LDH), D-dimer, interleukin-6 (IL-6), IL-10, and interferon-γ (IFN-γ) levels, as well as longer hospital stays (all P < 0.05). Multi-pathogen co-detection was found in 49.62% of MPP patients, and was more frequent in severe cases than in mild cases (54.05% vs. 39.51%, P < 0.05). The most common co-detected pathogens were rhinovirus, adenovirus, influenza A virus, Haemophilus influenzae, and Streptococcus pneumoniae. Among severe cases, the white blood cell (WBC) count and LDH, IL-6, and IL-10 levels were significantly higher in the multi-pathogen co-detection group compared to the MP alone group (P < 0.05).ROC analysis revealed that IL-6 and IL-10, especially in combination, effectively predicted multi-pathogen co-detection.Conclusions: Multi-pathogen co-infections substantially influence the severity of pediatric MPP. The findings highlight the diagnostic value of tNGS for identifying co-pathogens and underscore the predictive potential of inflammatory biomarkers (especially IL-6 and IL-10). The integration of tNGS and these biomarkers may facilitate early detection and targeted therapeutic interventions, thereby improving prevention and treatment outcomes in pediatric MPP.

Keywords: Mycoplasma pneumoniae, Child, Pneumonia, Pathogen co-detection rate, Targeted next-generation sequencing

Received: 18 Aug 2024; Accepted: 29 Apr 2025.

Copyright: © 2025 Dong, Li, YINGXUE, Chen, Zhang, Lv, Yang, Yanhua, Wang, Guo, Wang, Li, Lin, Luo, Lu, Lu and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Quan Lu, Shanghai Children's Hospital, Shanghai, China
Hanmin Liu, West China Second University Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.